جست‌وجوی استاد و پژوهشگر

• Neuroscience
• Neuropharmacology
• Neurodegenerative Diseases
• +۵ مورد دیگر

Professor Aideen Sullivan is Head of the Department of Anatomy and Neuroscience at University College Cork (UCC). With a career spanning over two decades at UCC, she leads research on neuroprotective therapies for Parkinson's disease, focusing on growth factors, stem cell applications, and epigenetic mechanisms. She established Ireland's first BSc in Neuroscience and co-developed the cross-College BSc in Medical and Health Sciences (CK707). BSc (First Class Honours) in Pharmacology, University College Dublin (1992) PhD in Neuropharmacology, University of Cambridge (1995) Her research program investigates Parkinson's disease through five key themes: viral vector delivery of neurotrophic factors, molecular mechanisms of neuroprotection, biomarker discovery, neuronal degeneration models, and stem cell-based treatments. She has secured significant grants from Health Research Board, Enterprise Ireland, and the Wellcome Trust. Recent publications (2022-2020) emphasize epigenetic regulation (HDAC inhibitors), microbiome-gut-brain axis interactions, and novel neurotrophic strategies. Articles highlight GDF5's neuroprotective effects, miRNA modulation, and molecular pathways like BMP-Smad and p38-MAPK. Scientific awards include: Postgraduate Certificate in Teaching and Learning (UCC, 2006) FETAC Certificate in Peer-Mentoring (2010) Leadership Foundation Aurora Programme Scholarship (2015) Over €2 million in research grants She mentors undergraduate and postgraduate students, chairs UCC's Athena SWAN 'Flexible Working' group, and serves as Editor-in-Chief of Neuronal Signaling . Her work spans laboratory research, public engagement, and educational innovation.

• Developmental Biology
• Cell Cycle Regulation
• Apoptosis
• +۷ مورد دیگر

Carmel Hensey serves as Associate Professor at University College Dublin's School of Biomolecular and Biomedical Science, where she has held multiple leadership positions including Head of Teaching and Learning (2011-2014) and Vice-Principal for Teaching and Learning for the College of Science (2014-2019). Her academic career at UCD spans from College Lecturer (1999-2007) to her current position as Associate Professor (2007-present). Dr. Hensey completed her foundational research training through extensive postdoctoral fellowships at Universitat Berne (1988-1991), University of Texas Health Sciences Centre (1992-1993), Roche Institute of Molecular Biology (1994-1995), and Columbia University (1995-1999). She further enhanced her pedagogical expertise with a Professional Certificate in University Teaching and Learning from UCD (2018) and a Digital Badge for Universal Design in Teaching and Learning (2019). Her primary research investigates reproduction and early development using Xenopus laevis as a model system, with particular focus on identifying genes that regulate developmental competence during meiosis and early embryonic stages. Her work spans cell cycle regulation, apoptosis mechanisms, chromatin remodeling factors (especially ATRX), and progesterone signaling pathways in oocyte maturation. She has made significant contributions to understanding how DNA damage responses are integrated with developmental programs and how chromatin remodeling affects oocyte quality. Analysis of Dr. Hensey's publication record reveals a consistent research trajectory from early work on DNA damage responses and apoptosis in Xenopus embryos to more recent investigations of oocyte quality control mechanisms across model systems. Her research demonstrates sophisticated integration of developmental biology, reproductive physiology, and molecular cell biology approaches, with particular emphasis on translational relevance to understanding developmental competence. Dr. Hensey has supervised 8 PhD students and 4 MSc students to completion. Her teaching responsibilities include coordination of Toxicology and Professional Placement modules, and instruction in nervous system development, advanced pharmacology, and cell growth/differentiation/death processes. She has also contributed to educational scholarship through cross-disciplinary collaborations in chemical engineering education. Her academic leadership extends to curriculum development as Project Champion for Curriculum Review and Enhancement (2015-2017) and as an Extern Examiner for National University of Ireland, Maynooth (2018-2021), demonstrating her commitment to educational excellence across multiple institutional contexts.

• Toxicology
• Pharmacology
• Renal Toxicology
• +۵ مورد دیگر

Tara McMorrow is an Associate Professor of Pharmacology and Toxicology at University College Dublin's School of Biomolecular and Biomedical Science and a Conway Research Fellow. She serves as Director of the UCD Centre for Toxicology and Academic Director of graduate programs in Toxicology and Regulatory Affairs. Previously, she was Associate Dean of Science (2019-2024) and Chair of the UCD Academic Council Committee on Student Appeals and Complaints. Dr. McMorrow earned her BSc and PhD in Science from NUI Galway, with her 1995 PhD focusing on molecular biology funded by Enterprise Ireland. She completed postdoctoral work at Erasmus University in Rotterdam and at UCD before being appointed Lecturer in Pharmacology in 2005. She was promoted to Senior Lecturer in 2014 and Associate Professor in 2016. She also earned a Graduate Diploma in University Teaching and Learning from UCD in 2013. Her research focuses on toxicology and the development of new approach methodologies (NAMs) in toxicity testing, with particular expertise in renal toxicology, chemical carcinogenesis, primary cilia biology, and biomarker discovery. Her work bridges basic science and clinical applications, examining mechanisms of kidney injury, diabetic nephropathy, and renal cancer. Analysis of her recent publications reveals strong emphasis on natural compounds like curcumin for cancer therapy, primary cilia as biomarkers for renal injury, and mechanisms of chemical-induced kidney damage. Dr. McMorrow has received numerous teaching awards including Teacher of the Year in 2013 and 2016, and has been recognized with UCD Seed Funding. She serves as an expert member of the Food Safety Authority of Ireland's Chemical Safety sub-committee and is active in professional organizations including the Irish Society of Toxicology (where she served as President 2016-2018) and the European Society of Toxicologists. She actively teaches across multiple disciplines including Science, Medicine, Nursing, and graduate programs in Toxicology, Regulatory Affairs, and Biotechnology. Her leadership extends to curriculum development as she was previously the Curriculum Review and Enhancement Project Champion for graduate taught programs in the College of Science (2015-2017).

• Bionanomaterials
• Single-Molecule Force Measurements
• Biosensing and In Vitro Diagnostics
• +۳ مورد دیگر

Professor Gil Lee holds the Stokes Full Professor of Physical Chemistry position at the University College Dublin, School of Chemistry . With a B.S. and Ph.D. in Chemical Engineering from Purdue University and University of Minnesota respectively, he transitioned to academia after postdoctoral research at the American Society of Engineering Education and a research engineer role at the Naval Research Laboratory. His career spans associate professorship at Purdue University (2000-2008) and adjunct roles, showcasing a trajectory marked by innovation in biomagnetic technologies . Education B.S. Chemical Engineering, Purdue University (1987) Ph.D. Chemical Engineering, University of Minnesota (1992) Postdoctoral Fellow, American Society of Engineering Education (1995) Executive Education Global EMBA, TRIUM (2016) His research is driven by three key areas : Bionanomaterials : Development of superparamagnetic microparticles for biological separations, drug delivery, and hyperthermia therapy. Techniques include iron-gold nanorods and self-assembled iron oxide nanoparticles with controlled surface chemistry. Single-Molecule Force Analysis : Pioneering work in atomic force microscopy (AFM) for quantitative force measurements, including streptavidin-biotin bond lifetime studies and magnetic tweezers for parallel ligand-receptor analysis. Biosensing & In Vitro Diagnostics : Innovations in immunomagnetic cell separation, magnetophoretic sensing, and microfluidic devices for rapid pathogen detection and cancer diagnostics. His scientific awards include the Stokes Chair (2008), E.T.S. Walton Fellowship (2006), and multiple Edison Patent Awards. He has received grants for projects in cancer diagnostics and microfluidic technologies . His teaching activities focus on advanced physical chemistry modules, emphasizing kinetics and thermodynamics, with roles as module coordinator since 2014.

• Cancer
• Cancer Immunology
• Caspases
• +۵ مورد دیگر

Dr. Emma Creagh is an Associate Professor in the Department of Biochemistry within the School of Biochemistry and Immunology at Trinity College Dublin. Her research focuses on the intersection of inflammation, immunology, and cancer, particularly examining the role of inflammatory caspases in disease progression across multiple organ systems. Dr. Creagh's research interests span several critical areas of biomedical science: Cancer and Cancer Immunology, with particular focus on gastrointestinal cancers The role of caspases in inflammation and immune responses Inflammasome-mediated inflammation pathways The connection between chronic inflammation and cancer development Esophageal and colorectal cancer mechanisms TLR signaling in disease progression Analysis of Dr. Creagh's recent publications reveals a cohesive research program centered on inflammatory caspases (particularly -1, -4, -5, and -11) and their diverse roles in disease. Her work spans gastrointestinal cancers (particularly esophageal and colorectal), inflammatory bowel disease, allergic airway inflammation, and psoriasis, demonstrating how these enzymes regulate immune responses across multiple pathological contexts. A significant portion of her research investigates the molecular mechanisms linking inflammation to cancer development, with implications for novel therapeutic targets. Dr. Creagh has received numerous scientific awards and recognitions: Wellcome Trust Career Development Fellowship (2006-2011) Broad Medical Research Program Fellowship (2010-2012) TCD Pathfinder Award (2015) Winner of Oral presentation at Irish Society of Gastroenterology Meeting (2016) Voted 'Favorite Woman in Science' by TCD General Science Students (2017-2019) Senior Council Member of the Irish Association for Cancer Research (IACR) since 2020 Dr. Creagh maintains active collaborations with clinicians at St. Vincent's Hospital and participates in numerous national and international research networks. Her laboratory serves as a training ground for the next generation of immunologists and cancer researchers, with several students presenting their work at major conferences. She regularly presents her findings at specialized immunology meetings and gastroenterology conferences, contributing to the advancement of knowledge in inflammation-related diseases.

Cara Dalyمشاهده پروفایل

مدرس

• Plant Science
• Botany
• Programmed Cell Death
• +۴ مورد دیگر

Cara Daly is a Lecturer in the Department of Land Sciences at South East Technological University (SETU) , where she has worked since 2013. She serves as Programme Director for the SETU/Teagasc BSc in Horticulture and actively participates in the SETU Academic Council and Equality, Diversity & Inclusion (EDI) committees. Education: PhD in Plant Programmed Cell Death (2013), University College Dublin BSc (Hons) in Botany (2009), University College Dublin Research Interests focus on plant programmed cell death (PCD) mechanisms and their role in stress tolerance. Her work investigates how PCD dynamics influence plant responses to abiotic (e.g., salt stress) and biotic stressors, alongside micropropagation techniques and exometabolite analysis via HPLC/mass spectrometry. Recent projects explore antioxidant and anti-inflammatory properties in wild plant extracts. Publication Trends highlight consistent contributions to plant stress biology, with a emphasis on Arabidopsis thaliana as a model organism, proline-mediated stress tolerance, calcium signaling in PCD, and chloroplast-dependent cell death pathways. Her research bridges fundamental plant biology with agricultural applications. Scientific Recognition Winner of the SETU Vicky Phelan Equality, Diversity and Inclusion award (2023) Teaching includes Plant Biology, Scientific Writing, Data Analysis, and Lab Skills for plant micropropagation. She also mentors PhD students and contributes to university governance through EDI initiatives.

• Virology
• Molecular Virology
• Viral Pathogenesis
• +۱۴ مورد دیگر

Martina Scallan is a Lecturer in the Department of Microbiology at University College Cork (UCC), where she has been an active faculty member since 1997. She teaches and examines over 500 undergraduate students annually, delivering modules in Virology, Epidemiology, and Microbial Pathogenesis, and supervises final-year research projects in Microbiology and Biomedical Science. She also contributes to postgraduate programs including the M.Sc. in Molecular Cell Biology, Bio-innovation, and Biomedical Science. B.Sc. in Biochemistry, University of St. Andrews, Scotland (1987) Ph.D. in Virology, Medical Research Council, Institute of Virology, Glasgow, Scotland (1991) Her research expertise lies in molecular and classical virology, with a focus on virus-host interactions, viral vectors for gene therapy, and cell culture systems. She established a Category II Virus Research Laboratory at UCC, supporting research into therapeutic applications for cancer, neurodegeneration, and genetic diseases such as cystic fibrosis and cystinosis. Recent projects include the use of 3D culture systems for virus-vector production and gene editing using ZFNs and CRISPR/Cas9. Her recent publications (2010–2013) emphasize gene editing for cystic fibrosis and cystinosis, viral vectors in cancer immunotherapy, and molecular virology of hepatitis C and neurotropic viruses. These works reflect a strong interdisciplinary trend combining virology, molecular biology, immunology, and translational medicine. New product and process development in animal cell bioprocessing and tissue engineering – Enterprise Ireland (€6,500) Permanent correction of 80% of disease-causing mutations in human CF cells – Cystic Fibrosis Trust (€59,000) Gene repair Conference – Health Research Board (€14,000) Cystinosis Gene Repair – Other (€110,329) Towards a cure of Cystinosis – Health Research Board (€148,425) Pathogenesis – Science Foundation of Ireland (€666,077) HEA Cycle 3 Project – Higher Education Authority (€170,769) Martina Scallan has supervised 9 PhD and 9 M.Sc. students to completion, including notable graduates such as Katrin Kaschig, Sara Collins, and Jennifer Hollywood, whose work focused on gene repair and viral vectors. She has served on key academic committees including the School of Microbiology Teaching, Learning and Student Experience (TLSE) Committee and the Teaching & Curriculum Development Committee. Her lab fosters collaboration within UCC and internationally, particularly in the development of innovative viral vector platforms for therapeutic use.

• Mammalian Energy Metabolism
• Mitochondrial Bioenergetics
• Cancer Metabolism
• +۵ مورد دیگر

Professor Richard Porter is a distinguished academic in the field of Biochemistry at Trinity College Dublin. He serves as a Professor in Biochemistry and previously held significant leadership roles including Director of Teaching and Learning in the School of Biochemistry & Immunology (Postgraduate) from 2004-2008 & 2016-2017, and Head of Biochemistry from 2011-2017. Elected as a Fellow of Trinity College Dublin in 2007, he has been a lecturer and Principal Investigator at Trinity since 1997. His academic journey began with an undergraduate degree in Biochemistry at Trinity College, followed by a Ph.D. with Prof. John M. Scott focusing on carbon-one metabolism, and a three-year postdoctoral position at the University of Cambridge with Prof. Martin D. Brand. His educational background includes: Undergraduate degree in Biochemistry at Trinity College Dublin Ph.D. with Prof. John M. Scott in carbon-one metabolism Postdoctoral position at the Department of Biochemistry, University of Cambridge with Prof. Martin D. Brand Health Research Board (HRB) Fellowship in Prof. Clive William's laboratory in Trinity Professor Porter's research spans several interconnected areas of biochemistry and metabolism, with a particular focus on mammalian energy metabolism . His work explores the molecular basis of metabolic rate, mitochondrial bioenergetics, and the role of uncoupling proteins in various physiological contexts. A significant portion of his recent research investigates cancer metabolism, particularly the role of interleukin-6 in oral squamous cell carcinoma and the metabolic programming that enables cancer cells to resist anoikis (cell death due to detachment). His laboratory has also made groundbreaking discoveries in equine genetics, identifying the biochemical basis of the "speed gene" in Thoroughbred horses, which has led to practical applications in the equine industry. His extensive publication record demonstrates a clear evolution from fundamental studies on mitochondrial function and uncoupling proteins toward more applied research in cancer metabolism and equine performance genetics. Recent work shows increasing focus on translational applications, with several projects moving toward clinical trials, particularly in the area of cancer cachexia where his team has identified cannabinoid analogues that can prevent muscle wasting in cancer patients. Professor Porter's scientific achievements have been recognized through several prestigious awards: Fellow of Trinity College Dublin (2007) Provost Teaching Award commendation from Trinity College Dublin (2014) Shortlisted for Knowledge Ireland (KTI) Award (2018) Lucker-Cobbe Award As an educator and mentor, Professor Porter has supervised numerous PhD and Master's students whose work appears in his publication record. His research is supported by a substantial grant portfolio exceeding €0.5 million, with funding from diverse sources including Science Foundation Ireland, The Health Research Board, Teagasc, Trinity College Dublin, Enterprise Ireland Innovation Partnership Programme (in collaboration with Plusvital), and Artelo plc. He has also consulted for Price Waterhouse Coopers in the area of R&D Tax Credits, demonstrating the commercial relevance of his work. Professor Porter leads a dynamic research group that includes postdoctoral researchers, technical staff, and students. His laboratory maintains strong collaborations with prominent international laboratories, both academic and industrial. Notably, his work on equine genetics has resulted in the discovery that led to the world's first nutrigenomic product for Thoroughbred horses (EnerGene-Q10 by Plusvital). His research group is currently involved in the Cancer Appetite Recovery Study (CAReS), a Phase 1b/2a clinical trial investigating a synthetic cannabinoid analogue for preventing cancer cachexia.

• Colorectal Cancer
• General Surgery
• Patient Safety
• +۴ مورد دیگر

Deborah McNamara is the President of Royal College of Surgeons in Ireland (RCSI) and a Consultant General & Colorectal Surgeon at Beaumont Hospital, Dublin. She holds an MB BAO BCh (Honours) from Trinity College Dublin, FRCSI (Gen Surg), MD, and honorary fellowships from the American College of Surgeons and Royal College of Physicians and Surgeons of Glasgow. Her career includes roles such as Programme Director of the National Higher Surgical Training Programme (2010–2013) and Clinical Director for Surgery at Beaumont Hospital (2014–2017). Her research focuses on colorectal cancer, surgical training, patient safety, and healthcare systems improvement. Notable contributions include developing Ireland’s first National Clinical Guidelines for colon and rectal cancer and leading initiatives on surgical handover quality and gender equality in surgery. She has authored over 220 peer-reviewed papers and secured grants for projects like surgical handover interventions and clinical handover issues in emergency surgery. Awards include the Patey Prize, AWS Olga Jonasson Award, and Millin Lecture. Her work emphasizes translational research, healthcare leadership, and advancing surgical education through evidence-based practices. She chairs key national and international committees, driving innovations in surgical care pathways and quality improvement.

• Proteomics
• Insect Biology
• Plant-Insect Interactions
• +۴ مورد دیگر

James Carolan is an Associate Professor in the Department of Biology at Maynooth University, Faculty of Science & Engineering. He holds a BA in Botany (Trinity College Dublin, 1998) and a PhD in Biology (Trinity College Dublin, 2004). His research focuses on proteomics and molecular interactions between organisms, particularly aphids, bumblebees, and pathogens. He secured Science Foundation Ireland funding for quantitative mass spectrometry facilities, enabling advanced research projects. Research areas include aphid-plant interactions, bumblebee conservation, marine bioadhesive studies, and parasitic diseases like Ascariasis. His work integrates genomics, transcriptomics, and proteomics to address agricultural, ecological, and biomedical challenges. Collaborations span international institutions, including the International Aphid Genomics Consortium and the Bumblebee Genome Initiative. Recent publications emphasize aphid effector proteins, glyphosate impacts on bumblebees, and proteomic responses to pathogens. His lab, Applied Proteomics Laboratory, develops bespoke proteomic strategies for non-model organisms. Conservation efforts include the Bumblebee Nest Initiative on campus to support pollinator populations.

• Cancer Research
• Cell Death Pathways
• Brain Tumors
• +۲ مورد دیگر

Dr. Brona Murphy is an Associate Professor in the Department of Physiology & Medical Physics and principal investigator within the Centre for Systems Medicine at the Royal College of Surgeons in Ireland (RCSI). She holds a B.Sc. in Biotechnology from NUI Galway (2000), PhD in Molecular Cell Biology from Trinity College Dublin (2004), and MSc in Leadership & Management from RCSI (2011). Her research focuses on understanding molecular mechanisms of cell death resistance in brain tumors to develop more effective cancer therapies. Research interests include: Molecular pathways of apoptosis in glioblastoma Overcoming treatment resistance in pediatric brain tumors Novel therapeutic strategies targeting cell death mechanisms Her research is funded by EI, HRB, SFI, NCRC and H2020 Framework Programme. She coordinates student research projects and leads the department's teaching programs. Scientific awards include: Stokes Lectureship from Science Foundation Ireland Health Research Board Post-Doctoral Fellowship Royal Irish Academy Science Writing Competition Winner Dr. Murphy supervises multiple PhD students investigating apoptosis mechanisms in brain tumors and leads an active research group focused on improving therapeutic outcomes for cancer patients.

• Cancer
• Drug Development
• Immunology
• +۵ مورد دیگر

Graeme Sullivan is a Lecturer in the School of Pharmacy and Biomolecular Sciences at RCSI. He holds a Ph.D. in Molecular Biology from Trinity College Dublin (2018) and has held postdoctoral positions in Prof. Martin's lab (TCD) and Prof. Ní Chonghaile's Targeted Therapeutics in Cancer (TTC) group at RCSI. His research focuses on cancer biology, immunology, and inflammation with particular emphasis on cytokine signaling (IL-36/IL-37 families), drug resistance mechanisms, and targeted therapies. Education: B.A. B.Dent.Sc. (Hons), Trinity College Dublin (2006) P.G. Dip. (Dent. Ed.), University of Bristol (2017) Ph.D. in Molecular Biology, Trinity College Dublin (2018) Research Interests: Cancer stem cells and microenvironment interactions Mechanisms of venetoclax resistance in hematological malignancies PROTAC technology for HDAC6 degradation IL-36/IL-37 cytokine activation pathways in inflammatory diseases Public Patient Involvement (PPI) in multiple myeloma research Grants & Awards: Irish Cancer Society Translational Fellowship (2021-2024) Irish Research Council Grant (2013-2017) Edmund Burke Entrance Exhibition Award Teaching: Lecturer in Pharmacy, Medicine, and Physician Associate programs Uses innovative pedagogical techniques in classroom and lab settings Supervises undergraduate/postgraduate students and serves on academic committees Labs & Affiliations: Current: Targeted Therapeutics in Cancer (TTC) group at RCSI Prior: Prof. Martin's Molecular Cell Biology Lab (TCD) Member of Athena SWAN committee Collaborations with Multiple Myeloma Ireland

Niall Barronمشاهده پروفایل

استاد

• Biomedical Engineering
• Biochemical Engineering
• Cellular and Molecular Biology
• +۵ مورد دیگر

Professor Niall Barron is a Professor of Biochemical Engineering at the School of Chemical and Bioprocess Engineering, University College Dublin (UCD), and a Principal Investigator at the National Institute for Bioprocessing Research and Training (NIBRT). He holds a BA (Mod) in Microbiology from Trinity College Dublin and a PhD in Applied Microbiology/Biochemistry from the University of Ulster (1997). His postdoctoral research at Baylor College of Medicine focused on nuclear steroid receptor function via genome engineering. He has held academic and research roles at Dublin City University (DCU), including Director of the National Institute for Cellular Biotechnology (NICB) from 2015–2017. His research focuses on genetic engineering strategies to improve recombinant protein production in CHO cells, AAV/LV vector manufacturing, and epigenetic regulation of bioprocess performance. He leads projects funded by industry and EU grants, including initiatives to enhance gene therapy vector production and mRNA methylation control. Education: BA (Mod) in Microbiology, Trinity College Dublin PhD in Applied Microbiology/Biochemistry, University of Ulster (1997) Research Interests: Targeted genome editing in CHO cells for improved biopharmaceutical production Optimization of AAV and LV vector systems for gene therapy miRNA and epitranscriptomic regulation of cellular processes Single-cell analysis to understand clonal variability and production instability Grants & Collaborations: Lead on grants from GSK, Enterprise Ireland, and Horizon 2020 (e.g., STACCATO, GeneClick) Focus on advancing bioprocess technologies and cell line engineering Teaching: Coordinates modules in biopharmaceutical manufacturing, biotechnology principles, and gene therapy processes Program Director for the MEngSc in Biopharmaceutical Manufacturing (Part-Time) Labs & Teams: Leads a multidisciplinary team at UCD and NIBRT focusing on biopharmaceutical engineering and cell line optimization

• Traumatic Brain Injury
• Neuroinflammation
• Obesity-TBI Comorbidity
• +۴ مورد دیگر

Dr. Rebecca Henry is an Assistant Professor in Pharmacology at the School of Biomolecular and Biomedical Science, University College Dublin, where she joined in 2024 as a Royal Society - SFI University Research Fellow. Previously, she held a lectureship position at the Department of Anatomy & Neuroscience, University College Cork starting in 2021. Her educational background includes: B.Sc. (Hons) in Physiology from the University of Galway (2011) Ph.D. from the University of Galway (2015), investigating pharmacological modulation of the endocannabinoid system on TLR-induced neuroinflammation Postdoctoral training at the Shock Trauma and Anesthesiology Research Center (STAR), University of Maryland, Baltimore Certificate in Teaching and Learning in Higher Education from University College Cork (2022-2023) Johns Hopkins/University of Maryland Baltimore Collaborative Teaching Fellowship Program (2020-2021) Dr. Henry's research focuses on the neuroimmune interplay between obesity and traumatic brain injury (TBI). Her Henry Lab investigates how pre-existing metabolic dysfunction affects TBI outcomes, with particular emphasis on: Therapeutic potential of anti-obesity drugs in co-morbid diet-induced obesity and TBI Impact of environmental factors (exercise, diet) on TBI outcomes in obese patients Bi-directional relationship between the brain and periphery in obesity-TBI comorbidity Sex differences in neuroimmune responses to TBI and implications for treatment Analysis of her recent publications (2020-2025) reveals a strong focus on neuroinflammation mechanisms following TBI, particularly examining how obesity exacerbates TBI outcomes through altered immune responses. Her work spans from basic molecular mechanisms to clinical implications, with increasing emphasis on translational approaches to improve TBI outcomes in metabolically compromised patients. Her notable scientific achievement includes: Royal Society - SFI University Research Fellowship Dr. Henry serves as a PhD thesis supervisor and co-supervisor at University College Dublin. She has secured research funding including the SFI grant 'Investigation of the role of the GDF-15/GFRAL signalling axis in mediating neuroprotective effects in the presence of co-morbid diet-induced obesity and TBI' (2024-2027). Her teaching philosophy emphasizes active learning strategies, small group learning, and empowering students to take ownership of their learning. She holds formal teaching qualifications from both University College Cork and the Johns Hopkins/University of Maryland Baltimore Collaborative Teaching Fellowship Program.